Question 1

What is HCA Healthcare's P/E ratio?

Accepted Answer

HCA Healthcare (HCA) P/E ratio is 12.4× as of July 22, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month earnings (net income), using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/E ratio calculated?

Accepted Answer

P/E = Share Price ÷ Trailing Twelve-Month (TTM) Diluted EPS, or equivalently Market Capitalisation ÷ TTM Net Income. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/E ratio?

Accepted Answer

The price-to-earnings (P/E) ratio, also called the earnings multiple, measures how much investors pay per dollar of a company's trailing twelve-month (TTM) earnings. It is calculated as share price ÷ TTM diluted EPS (equivalent to market capitalisation ÷ TTM net income). A higher P/E implies the market is pricing in stronger future earnings growth or lower risk; a lower P/E can signal slower expected growth, higher risk, or potential undervaluation.

Question 4

What is a good P/E ratio for HCA Healthcare?

Accepted Answer

There is no universal "good" P/E. As a rule of thumb, the S&P 500 has historically averaged a P/E in the mid-to-high teens; mature, slow-growth businesses commonly trade in the 10–18× range, while high-growth or asset-light companies often trade at 25–50×+. What matters is the comparison to sector peers and to the company's own historical range. For HCA Healthcare specifically, the relevant sector benchmark is the current sector median of 24.2×.

Question 5

Is HCA Healthcare's P/E ratio high or low?

Accepted Answer

HCA Healthcare's P/E ratio of 12.4× is below its own 5-year average of 13.4× and below the sector median of 24.2×. That places the current reading at the 25th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is HCA Healthcare's historical P/E ratio range?

Accepted Answer

In the available daily series, HCA Healthcare (HCA) P/E ratio has ranged from a low of 3.9× in 2011 to a high of 19.7× in 2025. The 5-year average is 13.4× and the 5-year median is 13.7×.

Question 7

What was HCA Healthcare's P/E ratio in 2025?

Accepted Answer

HCA Healthcare (HCA) P/E ratio at the end of 2025 was 15.9×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month earnings figure available at that date.

Question 8

Why does HCA Healthcare's P/E ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (earnings). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$108B	$6.78B	15.9×	+2.7×	Dec 31, 2025
2024	$75.7B	$5.76B	13.1×	-0.6×	Dec 31, 2024
2023	$71.9B	$5.24B	13.7×	+1.9×	Dec 31, 2023
2022	$66.6B	$5.64B	11.8×	+0.5×	Dec 31, 2022
2021	$78.5B	$6.96B	11.3×	-3.6×	Dec 31, 2021
2020	$55.8B	$3.75B	14.9×	+0.6×	Dec 31, 2020
2019	$50B	$3.51B	14.3×	+3.0×	Dec 31, 2019
2018	$42.7B	$3.79B	11.3×	-2.6×	Dec 31, 2018
2017	$30.8B	$2.22B	13.9×	+4.4×	Dec 31, 2017
2016	$27.4B	$2.89B	9.5×	-3.2×	Dec 31, 2016
2015	$27B	$2.13B	12.7×	-3.8×	Dec 31, 2015
2014	$30.9B	$1.88B	16.5×	+3.0×	Dec 31, 2014
2013	$21B	$1.56B	13.5×	+5.1×	Dec 31, 2013
2012	$13.4B	$1.61B	8.3×	+4.4×	Dec 31, 2012
2011	$9.62B	$2.47B	3.9×	-7.1×	Dec 31, 2011
2010	$13.2B	$1.21B	11.0×	-1.6×	Dec 31, 2010
2009	$13.2B	$1.05B	12.6×	-7.1×	Dec 31, 2009
2008	$13.2B	$673M	19.7×	+4.5×	Dec 31, 2008
2007	$13.2B	$874M	15.1×	+2.4×	Dec 31, 2007
2006	$13.2B	$1.04B	12.8×	+4.0×	Dec 31, 2006
2005	$12.6B	$1.42B	8.8×	-1.8×	Dec 31, 2005
2004	$13.3B	$1.25B	10.6×	-0.7×	Dec 31, 2004
2003	$15.1B	$1.33B	11.4×	-7.6×	Dec 31, 2003
2002	$15.8B	$833M	18.9×	—	Dec 31, 2002


Agilent Technologies (A)	23.1×
Medtronic (MDT)	22.2×
McKesson (MCK)	22.2×
Illumina (ILMN)	21.7×
ResMed (RMD)	21.6×
GE HealthCare (GEHC)	21.6×
Pfizer (PFE)	21.1×
Quest Diagnostics (DGX)	21.1×
Henry Schein (HSIC)	21.0×
AptarGroup (ATR)	20.9×
IQVIA (IQV)	20.7×
Biogen (BIIB)	19.7×
Zoetis (ZTS)	18.9×
Gilead Sciences (GILD)	18.8×
Humana (HUM)	18.5×
Regeneron Pharmaceuticals (REGN)	18.2×
Bristol-Myers Squibb (BMY)	17.0×
Elevance Health (ELV)	17.0×
AstraZeneca (AZN)	14.7×
DaVita (DVA)	13.3×
Incyte (INCY)	13.1×
Cigna (CI)	11.1×
Novo Nordisk (NVO)	8.6×
Solventum (SOLV)	7.9×
Universal Health Services (UHS)	7.2×

P/E Ratio for HCA Healthcare (HCA) 2002-2026

P/E Ratio daily chart for HCA Healthcare (HCA)

Historical P/E Ratio for HCA Healthcare (HCA) from 2002 to 2025

About P/E Ratio at HCA Healthcare (HCA)

HCA Healthcare P/E Ratio by Year

HCA Healthcare P/E Ratio 2025: 15.9×

HCA Healthcare P/E Ratio 2024: 13.1×

HCA Healthcare P/E Ratio 2023: 13.7×

HCA Healthcare P/E Ratio 2022: 11.8×

HCA Healthcare P/E Ratio 2021: 11.3×

Sector peers by P/E Ratio — chart

Sector peers by P/E Ratio — table

Frequently asked questions

HCA Healthcare (HCA) Key Financials